Cerenome (PSTV) Shares Outstanding (2010 - 2026)
Plus Therapeutics (PSTV) posted quarterly Shares Outstanding (Entity) of $6.9 million for Q1 2026, up 895.53% year-over-year from $690322.0 in Q1 2025, and up 120.82% quarter-over-quarter from $3.1 million in Q4 2025.
Cerenome (PSTV) Shares Outstanding (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Shares Outstanding (Entity) for 17 consecutive years, with $6.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 895.53% year-over-year to $6.9 million; the TTM figure through Mar 2026 stood at $6.9 million (up 895.53% YoY), while the FY2025 annual figure was $3.1 million, up 1164.14% from the prior year.
- Shares Outstanding (Entity) rose to $6.9 million in Q1 2026 per PSTV's latest filing, from $3.1 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $6.9 million in Q1 2026 and bottomed at $59223.0 in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $1.1 million across 5 years, with a median of $180906.0 in 2024.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) jumped 48.47% — and 2025, when it surged 1267.52%.
- Plus Therapeutics' Shares Outstanding (Entity) stood at $70049.0 in 2022, then jumped by 79.36% to $125637.0 in 2023, then soared by 95.95% to $246190.0 in 2024, then jumped by 1164.14% to $3.1 million in 2025, then surged by 120.82% to $6.9 million in 2026.
- Business Quant data shows PSTV's Shares Outstanding (Entity) at $6.9 million in Q1 2026, $3.1 million in Q4 2025, and $4.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | 6.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.65 Mn |
| Dec 31, 2025 | 3.11 Mn |
| Sep 30, 2025 | 4.30 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 582,669.00 |
| Dec 31, 2024 | 265,610.00 |
| Sep 30, 2024 | 314,231.00 |
| Jun 30, 2024 | 260,033.00 |
| Mar 31, 2024 | 172,869.00 |
| Dec 31, 2023 | 125,637.00 |
| Sep 30, 2023 | 129,014.00 |
| Jun 30, 2023 | 100,375.00 |
| Mar 31, 2023 | 92,847.00 |
| Dec 31, 2022 | 70,049.00 |
| Sep 30, 2022 | 73,214.00 |
| Jun 30, 2022 | 59,376.00 |
| Mar 31, 2022 | 57,381.00 |
| Dec 31, 2021 | 32,254.00 |
| Sep 30, 2021 | 35,389.00 |
| Jun 30, 2021 | 30,140.00 |